Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L'Effet du rémifentanil Sur la sensibilité à la Douleur mesurée Objectivement
NCT07568405Enrolling by invitation
- Sponsor
- Université libre de Bruxelles
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of remifentanil in pain, sponsored by Université libre de Bruxelles. Primary endpoint: Variation in the pressure pain threshold. Started Jan 2026; status: enrolling by invitation.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT07568405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568405.